Hyperforin Exhibits Antigenotoxic Activity on Human and Bacterial Cells

Area of Science:

• Pharmacology
• Genetics
• Natural Products

Background:

• Hyperforin (HF) is a key compound in St. John's wort (Hypericum perforatum L.), known for its antidepressant properties.
• The antigenotoxic potential of HF, particularly concerning primary genetic damage, gene mutations, and chromosome aberrations, has not been comprehensively investigated.
• Understanding HF's effects on genetic material is crucial for evaluating its broader therapeutic and chemopreventive applications.

Purpose of the Study:

• To investigate the antigenotoxic, antimutagenic, and anticlastogenic effects of Hyperforin (HF).
• To assess HF's protective capacity against different classes of mutagens using multiple in vitro test systems.
• To provide a comprehensive evaluation of HF's impact on primary genetic damage, gene mutations, and chromosomal aberrations.

Main Methods:

• Alkaline comet assay on human lymphocytes to evaluate primary genetic damage.
• Ames test using Salmonella typhimurium strains (TA97, TA98, TA100) to assess antimutagenic effects.
• In vitro mammalian chromosome aberration test on HepG2 and VH10 cell lines to determine anticlastogenic activity.

Main Results:

• Hyperforin (HF) demonstrated significant antigenotoxicity against the oxidative mutagen zeocin in the comet assay.
• HF exhibited antimutagenic activity against 4-nitroquinoline-1-oxide in the Ames test.
• HF showed a notable anticlastogenic effect against benzo(a)pyrene and cisplatin in the chromosome aberration test.

Conclusions:

• Hyperforin (HF) possesses significant antigenotoxic, antimutagenic, and anticlastogenic properties.
• HF effectively protects against various mutagens, including oxidative, diagnostic, and genotoxic agents.
• These findings support the potential of Hyperforin as a protective agent against genetic damage.